Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Tongxinluo is a kind of Chinese patent drug,which could promote blood circulation.Recent
reports suggested that tongxinluo's effectiveness in reducing the thrombin activity.In this
prospective randomized study,all patients in control group will receive blank placebo ,all
patients in test group will receive tongxinluo.All patients will be followed up for one year.